This site is intended for healthcare professionals
Drug news

ChemoCentryx and VFMCRP announce positive data from phase III ADVOCATE trial showing superiority of avacopan over standard of care in ANCA-associated vasculitis.

Read time: 3 mins
Last updated:27th Nov 2019
Published:27th Nov 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest